A Study of Mitoxantrone Hydrochloride Liposome Infusion

NCT02856685 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: Mitoxantrone Hydrochloride Liposome

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.